Search

Subject adaptive -- Bayesian -- Choi -- dasatinib -- phase 2 -- sarcoma

1. SARC009: Phase 2 study of dasatinib in patients with previously treated, high‐grade, advanced sarcoma. Issue 6 (28th December 2015)

Authors:
Schuetze, Scott M.; Wathen, J. Kyle; Lucas, David R.; Choy, Edwin; Samuels, Brian L.; Staddon, Arthur P.; Ganjoo, Kristen N.; von Mehren, Margaret; Chow, Warren A.; Loeb, David M.; Tawbi, Hussein A.; Rushing, Daniel A.; Patel, Shreyaskumar R.; Thomas, Dafydd G.; Chugh, Rashmi; Reinke, Denise K.; ...
Journal:
Cancer
Issue:
Volume 122:Issue 6(2016)
Page Start:
868
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search

  • adaptive -- Bayesian -- Choi -- dasatinib -- phase 2 -- sarcoma 1